Cravath, Swaine & Moore LLP has advised DRI Healthcare Trust. Ropes & Gray LLP has advised Bain Capital. DRI Healthcare Trust (TSX: DHT:UN) (TSX: DHT:U) has...
DRI Healthcare to Acquire Tavapadon Royalty Rights for US$316 Million
Thermo Fisher to Sell Microbiology Business to Astorg for $1.075 Billion
Cravath, Swaine & Moore LLP, Axinn, Veltrop & Harkrider LLP, Hogan Lovells, and Perella Weinberg Partners and Wells Fargo have advised Thermo Fisher Scientific. Latham &...
The Commissioner of Financial Protection and Innovation v. Silvergate
Cravath Swaine & Moore advised Silvergate in the matter. California-based company Silvergate Capital Corporation (Silvergate) announced it has agreed to settlements with the Board of Governors...
Hess Midstream’s $391.2 Million Common Stock Offering
Latham & Watkins represented Hess Midstream LP in the offering, and Cravath Swaine & Moore represented the underwriter. Hess Midstream LP (NYSE: HESM) announced its $391.2...
CNA Financial Corporation’s $500 Million Registered Notes Offering
Mayer Brown advised CNA Financial Corporation on the offering, Cravath, Swaine & Moore represented the underwriters. CNA Financial Corporation (NYSE: CNA) announced its $500 million registered notes offering...
Amentum’s $1.9 Billion Acquisition of PAE Incorporated
Goodwin Procter, Morgan, Lewis & Bockius and Nichols Liu advised PAE, while Cravath, Swaine & Moore advised Amentum and Arnold & Porter Kaye Scholer acted as...